Your Good Partner in Biology Research

BCAM

BCAM蛋白全称为基底细胞黏附分子,也被称为Lutheran血型抗原或CD239,是一种跨膜糖蛋白。该蛋白主要表达于红细胞、上皮细胞及多种肿瘤细胞表面,通过与细胞外基质中的层粘连蛋白结合参与细胞黏附及迁移过程。研究发现BCAM在镰状细胞病中异常活跃,其与血管内皮细胞的相互作用加剧了红细胞的滞留,导致血管阻塞危象的发生。在恶性肿瘤领域,BCAM的高表达与卵巢癌、胰腺癌的转移密切相关,可能通过激活特定激酶促进肿瘤细胞侵袭。近年来针对BCAM的靶向治疗逐渐受到关注,已有研究团队开发出阻断BCAM与层粘连蛋白结合的单克隆抗体,在动物模型中显示出抑制肿瘤转移的效果。2022年一项针对镰状细胞病的II期临床试验中,BCAM抑制剂联合抗凝血疗法使患者疼痛危象发生率降低40%,目前该靶点的双功能抗体药物已进入临床前评估阶段。

热销产品

BCAM Antibody (CSB-PA341920LA01HU)

验证数据

CSB-PA341920LA01HU

Immunohistochemistry of paraffin-embedded human pancreatic cancer using CSB-PA341920LA01HU at dilution of 1:100

CSB-PA341920LA01HU

Immunohistochemistry of paraffin-embedded human kidney tissue using CSB-PA341920LA01HU at dilution of 1:100

CSB-PA341920LA01HU

Immunofluorescence staining of HepG2 cells with CSB-PA341920LA01HU at 1:200, counter-stained with DAPI. The cells were fixed in 4% formaldehyde, permeabilized using 0.2% Triton X-100 and blocked in 10% normal Goat Serum. The cells were then incubated with the antibody overnight at 4°C. The secondary antibody was Alexa Fluor 488-congugated AffiniPure Goat Anti-Rabbit IgG(H+L).

BCAM Antibodies

BCAM for Homo sapiens (Human)

BCAM Proteins

BCAM Proteins for Homo sapiens (Human)